Life threatening haemorrhagic events associated with the administration of low-molecular-weight-heparin [6]

Thrombosis and Haemostasis

Volumn 91, Issue 4, 2004, Pages 833-834

  Kavanagh, Dara ^a   Hill, Arnold D K ^b   Martin, Sean ^b   Power, Colm ^b   McDermott, Enda W ^b   O'Higgins, Niall ^b   Murphy, Karen ^b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; FRESH FROZEN PLASMA; LOW MOLECULAR WEIGHT HEPARIN;

ABDOMINAL BLEEDING; ACUTE HEART FAILURE; ADULT; AGED; CAUSE OF DEATH; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG INDICATION; ERYTHROCYTE TRANSFUSION; FATALITY; FEMALE; HOSPITALIZATION; HUMAN; HYPOVOLEMIC SHOCK; INTENSIVE CARE UNIT; LETTER; LUNG EMBOLISM; MALE; MUSCLE BLEEDING; PAIN; PRIORITY JOURNAL; RETROPERITONEAL HEMORRHAGE; RISK BENEFIT ANALYSIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOSIS; THROMBOEMBOLISM;

EID: 1842738075     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614277     Document Type: Letter

References (2)

1. Weitz JI. Low molecular weight heparins. N Engl J Med 1997; 337: 688-98.
2. Task Force of the European Society of Cardiology. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST segment elevation. Eur Heart J 2000; 21: 1406-32.